G01N 2333/162
Env
Official title: env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site
G01N2333/162 (Env) appears on 131 US grants and 141 published applications in this corpus.
Search patents in G01N- Granted patents
- 131
- Published applications
- 141
- Assignees
- 82
- Inventors
- 281
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 6 | 0 |
| 2001 | 7 | 3 |
| 2002 | 4 | 5 |
| 2003 | 6 | 9 |
| 2004 | 1 | 1 |
| 2005 | 2 | 4 |
| 2006 | 1 | 5 |
| 2007 | 4 | 2 |
| 2008 | 1 | 7 |
| 2009 | 4 | 1 |
| 2010 | 1 | 10 |
| 2011 | 4 | 8 |
| 2012 | 2 | 5 |
| 2013 | 4 | 5 |
| 2014 | 2 | 7 |
| 2015 | 2 | 8 |
| 2016 | 4 | 6 |
| 2017 | 8 | 10 |
| 2018 | 5 | 4 |
| 2019 | 10 | 7 |
| 2020 | 7 | 7 |
| 2021 | 1 | 4 |
| 2022 | 8 | 8 |
| 2023 | 1 | 4 |
| 2024 | 3 | 2 |
| 2025 | 1 | 7 |
| 2026 | 4 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of identifying HIV patients sensitive to therapy with gp120 CD4 binding site-directed antibodies24 Feb 2026US 12,559,546 B2Gilead Sciences, Inc.
- Neutralizing antibodies to GP120 and their use10 Feb 2026US 12,545,719 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Anti-HIV antibodies27 Jan 2026US 12,534,516 B2International AIDS Vaccine Initiative
- Exosome-mediated diagnosis of hepatitis virus infections and diseases6 Jan 2026US 12,517,129 B2Morehouse School of Medicine
- Neutralizing antibodies to GP120 and their use21 Jan 2025US 12,202,886 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Assays and reagents for the detection of soluble gp12027 Aug 2026US 2026/0251654 A1
- Anti-hiv antibodies30 Jul 2026US 2026/0217801 A1International AIDS Vaccine Initiative
- Hiv gp41 variants for immunodiagnostic assays25 Sep 2025US 2025/0298022 A1Roche Diagnostics Operations, Inc.
- Antibody specific capture agents, compositions, and methods of using and making28 Aug 2025US 2025/0270259 A1California Institute of Technology
- Neutralizing antibodies to gp120 and their use3 Jul 2025US 2025/0215068 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
Most cited
By later US patents
- Methods and kits for the amplification of thin film based assays158US 5,955,377 ABiostar, Inc. · 1999
- Yeast-based delivery vehicles89US 5,830,463 AUniversity Technology Corporation · 1998
- Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases78US 5,413,914 AThe Regents of the University of Colorado · 1995
- Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes67US 4,839,288 AInstitut Pasteur · 1989
- Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits43US 5,079,342 AInstitut Pasteur · 1992